328 related articles for article (PubMed ID: 35883477)
1. Monoterpenes as Sirtuin-1 Activators: Therapeutic Potential in Aging and Related Diseases.
Sousa C; Mendes AF
Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883477
[TBL] [Abstract][Full Text] [Related]
2. Molecular and Cellular Characterization of SIRT1 Allosteric Activators.
Schultz MB; Rinaldi C; Lu Y; Amorim JA; Sinclair DA
Methods Mol Biol; 2019; 1983():133-149. PubMed ID: 31087296
[TBL] [Abstract][Full Text] [Related]
3. In Silico Design of Novel Sirtuin 1 Enzyme Activators for the Treatment of Age-related Diseases and Life Span.
Ertan-Bolelli T; Bolelli K
Curr Comput Aided Drug Des; 2021; 17(3):412-420. PubMed ID: 32321406
[TBL] [Abstract][Full Text] [Related]
4. Polyphenols as Caloric-Restriction Mimetics and Autophagy Inducers in Aging Research.
Yessenkyzy A; Saliev T; Zhanaliyeva M; Masoud AR; Umbayev B; Sergazy S; Krivykh E; Gulyayev A; Nurgozhin T
Nutrients; 2020 May; 12(5):. PubMed ID: 32397145
[TBL] [Abstract][Full Text] [Related]
5. Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease.
Tovar-Palacio C; Noriega LG; Mercado A
Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277012
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between age accumulated DNA-damage and the SIRT1-AKT-GSK3ß axis in urine derived renal progenitor cells.
Erichsen L; Adjaye J
Aging (Albany NY); 2022 Sep; 14(20):8179-8204. PubMed ID: 36170022
[TBL] [Abstract][Full Text] [Related]
7. Impact of circadian disruption on health; SIRT1 and Telomeres.
Osum M; Serakinci N
DNA Repair (Amst); 2020 Dec; 96():102993. PubMed ID: 33038659
[TBL] [Abstract][Full Text] [Related]
8. The anti-aging, metabolism potential of SIRT1.
Ghosh HS
Curr Opin Investig Drugs; 2008 Oct; 9(10):1095-102. PubMed ID: 18821472
[TBL] [Abstract][Full Text] [Related]
9. Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents.
Menendez JA; Joven J; Aragonès G; Barrajón-Catalán E; Beltrán-Debón R; Borrás-Linares I; Camps J; Corominas-Faja B; Cufí S; Fernández-Arroyo S; Garcia-Heredia A; Hernández-Aguilera A; Herranz-López M; Jiménez-Sánchez C; López-Bonet E; Lozano-Sánchez J; Luciano-Mateo F; Martin-Castillo B; Martin-Paredero V; Pérez-Sánchez A; Oliveras-Ferraros C; Riera-Borrull M; Rodríguez-Gallego E; Quirantes-Piné R; Rull A; Tomás-Menor L; Vazquez-Martin A; Alonso-Villaverde C; Micol V; Segura-Carretero A
Cell Cycle; 2013 Feb; 12(4):555-78. PubMed ID: 23370395
[TBL] [Abstract][Full Text] [Related]
10. Sirtuins and renal diseases: relationship with aging and diabetic nephropathy.
Kitada M; Kume S; Takeda-Watanabe A; Kanasaki K; Koya D
Clin Sci (Lond); 2013 Feb; 124(3):153-64. PubMed ID: 23075334
[TBL] [Abstract][Full Text] [Related]
11. Small molecule SIRT1 activators for the treatment of aging and age-related diseases.
Hubbard BP; Sinclair DA
Trends Pharmacol Sci; 2014 Mar; 35(3):146-54. PubMed ID: 24439680
[TBL] [Abstract][Full Text] [Related]
12. Sirtuin activators: designing molecules to extend life span.
Camins A; Sureda FX; Junyent F; Verdaguer E; Folch J; Pelegri C; Vilaplana J; Beas-Zarate C; Pallàs M
Biochim Biophys Acta; 2010; 1799(10-12):740-9. PubMed ID: 20601277
[TBL] [Abstract][Full Text] [Related]
13. The role of Sirtuin 1 and its activators in age-related lung disease.
Sun C; Bai S; Liang Y; Liu D; Liao J; Chen Y; Zhao X; Wu B; Huang D; Chen M; Wu D
Biomed Pharmacother; 2023 Jun; 162():114573. PubMed ID: 37018986
[TBL] [Abstract][Full Text] [Related]
14. Activators of Sirtuin-1 and their Involvement in Cardioprotection.
Granchi C; Minutolo F
Curr Med Chem; 2018; 25(34):4432-4456. PubMed ID: 29446717
[TBL] [Abstract][Full Text] [Related]
15. A review study on the modulation of SIRT1 expression by miRNAs in aging and age-associated diseases.
Zia A; Sahebdel F; Farkhondeh T; Ashrafizadeh M; Zarrabi A; Hushmandi K; Samarghandian S
Int J Biol Macromol; 2021 Oct; 188():52-61. PubMed ID: 34364937
[TBL] [Abstract][Full Text] [Related]
16. Regulation of SIRT1 and Its Roles in Inflammation.
Yang Y; Liu Y; Wang Y; Chao Y; Zhang J; Jia Y; Tie J; Hu D
Front Immunol; 2022; 13():831168. PubMed ID: 35359990
[TBL] [Abstract][Full Text] [Related]
17. The Beneficial Role of Sirtuin 1 in Preventive or Therapeutic Options of Neurodegenerative Diseases.
Liu H; Xu S; Wang C; Deng Y; Xu B; Yang T; Sun J; Liu W
Neuroscience; 2022 Nov; 504():79-92. PubMed ID: 36202276
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 and aging related signaling pathways.
Chen C; Zhou M; Ge Y; Wang X
Mech Ageing Dev; 2020 Apr; 187():111215. PubMed ID: 32084459
[TBL] [Abstract][Full Text] [Related]
19. A pharmacological review on SIRT 1 and SIRT 2 proteins, activators, and inhibitors: Call for further research.
Nandave M; Acharjee R; Bhaduri K; Upadhyay J; Rupanagunta GP; Ansari MN
Int J Biol Macromol; 2023 Jul; 242(Pt 1):124581. PubMed ID: 37105251
[TBL] [Abstract][Full Text] [Related]
20. Targeting Sirtuin 1 signaling pathway by ginsenosides.
Lou T; Huang Q; Su H; Zhao D; Li X
J Ethnopharmacol; 2021 Mar; 268():113657. PubMed ID: 33276056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
